GENZYME CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 33 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-12-31: Reporting owner DZAU VICTOR J; Form 4; Security Phantom Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-31: Reporting owner BERTHIAUME DOUGLAS A; Form 4; Security Phantom Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-10: Reporting owner Amello Jason; Form 3; Security Genzyme Restricted Stock Units; Transaction Holding.
- 2008-12-10: Reporting owner Amello Jason; Form 3; Security Genzyme Restricted Stock Units; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-12-31 | DZAU VICTOR J Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +302 302 owned after | $0.00 | 2009-01-05 | |
| 2008-12-31 | BERTHIAUME DOUGLAS A Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +420 420 owned after | $0.00 | 2009-01-05 | |
| 2008-12-10 holding as of filing | Amello Jason Other (CorpContrllr,ChiefAccntOfficer) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-12-10 | ||
| 2008-12-10 holding as of filing | Amello Jason Other (CorpContrllr,ChiefAccntOfficer) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-12-10 | ||
| 2008-09-30 | DZAU VICTOR J Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +198 198 owned after | $0.00 | 2008-10-02 | |
| 2008-09-30 | BERTHIAUME DOUGLAS A Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +262 262 owned after | $0.00 | 2008-10-02 | |
| 2008-06-30 | DZAU VICTOR J Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +255 255 owned after | $0.00 | 2008-07-02 | |
| 2008-06-30 | BERTHIAUME DOUGLAS A Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +369 369 owned after | $0.00 | 2008-07-02 | |
| 2008-05-23 holding as of filing | Meeker David P Officer (President LSD Therapeutics) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-05-23 | ||
| 2008-05-23 holding as of filing | GERAGHTY JAMES A Officer (Senior Vice President) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-05-23 | ||
| 2008-05-23 holding as of filing | DesRosier Thomas Officer (Sr VP General Counsel) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-05-23 | ||
| 2008-05-23 holding as of filing | Bamforth Mark R Officer (Sr.VP, Corp. Operations & Phar) | 3 | Genzyme Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-05-23 | ||
| 2008-05-22 | WYZGA MICHAEL S Officer (Executive VP and CFO) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | WIRTH PETER Officer (Executive Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | TERMEER HENRI A Director, Officer (Chmn, President and CEO) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,000 67,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | SMITH ALAN E Officer (Senior Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,083 8,083 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,083 8,083 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | Meeker David P Officer (President LSD Therapeutics) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | GERAGHTY JAMES A Officer (Senior Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | DesRosier Thomas Officer (Sr VP General Counsel) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,833 5,833 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | CSIMMA ZOLTAN A Officer (Senior VP, Human Resources) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,833 5,833 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | COLLIER EARL M JR Officer (Executive Vice President) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | Bamforth Mark R Officer (Sr.VP, Corp. Operations & Phar) | 4 | Genzyme Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $0.00 | 2008-05-27 | |
| 2008-05-22 | SYRON RICHARD F/CA Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | DZAU VICTOR J Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | COONEY CHARLES L Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | CARPENTER ROBERT J Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | BOUDREAUX GAIL Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-05-22 | BERTHIAUME DOUGLAS A Director | 4 | Genzyme DEP Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,500 2,500 owned after | $0.00 | 2008-05-23 | |
| 2008-03-31 | DZAU VICTOR J Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +208 208 owned after | $0.00 | 2008-04-02 | |
| 2008-03-31 | BERTHIAUME DOUGLAS A Director | 4 | Phantom Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +315 315 owned after | $0.00 | 2008-04-02 |